Home  >  Products  >  IGSF8 (immunoglobulin superfamily, member 8) Blocking Peptide (the middle region of IGSF8)(100ug)
IGSF8 (immunoglobulin superfamily, member 8) Blocking Peptide (the middle region of IGSF8)(100ug)

IGSF8 (immunoglobulin superfamily, member 8) Blocking Peptide (the middle region of IGSF8)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-IGSF8 Antibody (ARP59875_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59875
Size: 100ug
Weight: 65kDa
Gene: 93185
Format: Lyophilized powder
Target: IGSF8 may play a key role in diverse functions ascribed to CD81 and CD9 such as oocytes fertilization or hepatitis C virus function. IGSF8 may regulate proliferation and differentiation of keratinocytes. IGSF8 may be a negative regulator of cell motility: suppresses T-cell mobility coordinately with CD81, associates with CD82 to suppress prostate cancer cell migration, regulates epidermoid cell reaggregation and motility on laminin-5 with CD9 and CD81 as key linkers. IGSF8 may also play a role on integrin-dependent morphology and motility functions. IGSF8 may participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain.
Alternative names: CD316; CD81P3; EWI2; PGRL
See Full Product Listings >